1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biodefense Market, By Product
5.1 Introduction
5.2 Anthrax
5.3 Botulism
5.4 Cholera
5.5 Influenza
5.6 Nuclear
5.7 Smallpox
5.8 Other Products
6 Global Biodefense Market, By Detection Device
6.1 Introduction
6.2 Assays
6.3 Identifiers
6.4 Samplers
6.5 Detectors
6.6 Triggering Devices
6.7 Other Detection Devices
7 Global Biodefense Market, By Application
7.1 Introduction
7.2 Military
7.3 Civilian
8 Global Biodefense Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Care Centers
8.4 Government Institutions
8.5 Other End Users
9 Global Biodefense Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Siga Technologies Inc.
11.2 Emergent BioSolutions Inc.
11.3 Ichor Medical Systems
11.4 National Resilience, Inc.
11.5 Bavarian Nordic
11.6 Dynavax Technologies
11.7 Nighthawk Biosciences, Inc.
11.8 XOMA Corporation
11.9 Dynport Vaccine Company
11.10 Cleveland Biolabs
11.11 Ology Bioservices
11.12 Alnylam Pharmaceuticals Inc.
11.13 XOMA corporation
11.14 Altimmune Inc.
11.15 Biosearch Technologies
11.16 Bruker Detection
List of Tables
Table 1 Global Biodefense Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 4 Global Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 5 Global Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 6 Global Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 7 Global Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 8 Global Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 9 Global Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 10 Global Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 11 Global Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 12 Global Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 13 Global Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 14 Global Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 15 Global Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 16 Global Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 17 Global Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 18 Global Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 19 Global Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 20 Global Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 21 Global Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 22 Global Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 23 Global Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 24 Global Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 25 North America Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 26 North America Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 27 North America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 28 North America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 29 North America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 30 North America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 31 North America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 32 North America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 33 North America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 34 North America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 35 North America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 36 North America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 37 North America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 38 North America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 39 North America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 40 North America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 41 North America Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 42 North America Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 43 North America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 44 North America Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 45 North America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 46 North America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 47 North America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 48 North America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 49 Europe Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 50 Europe Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 51 Europe Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 52 Europe Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 53 Europe Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 54 Europe Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 55 Europe Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 56 Europe Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 57 Europe Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 58 Europe Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 59 Europe Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 60 Europe Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 61 Europe Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 62 Europe Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 63 Europe Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 64 Europe Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 65 Europe Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 66 Europe Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 67 Europe Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 68 Europe Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 69 Europe Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 70 Europe Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 71 Europe Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 72 Europe Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 73 Asia Pacific Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 74 Asia Pacific Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 75 Asia Pacific Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 76 Asia Pacific Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 77 Asia Pacific Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 78 Asia Pacific Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 79 Asia Pacific Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 80 Asia Pacific Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 81 Asia Pacific Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 82 Asia Pacific Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 83 Asia Pacific Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 84 Asia Pacific Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 85 Asia Pacific Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 86 Asia Pacific Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 87 Asia Pacific Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 88 Asia Pacific Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 89 Asia Pacific Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 90 Asia Pacific Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 91 Asia Pacific Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 92 Asia Pacific Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 93 Asia Pacific Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 94 Asia Pacific Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 95 Asia Pacific Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 96 Asia Pacific Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 97 South America Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 98 South America Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 99 South America Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 100 South America Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 101 South America Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 102 South America Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 103 South America Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 104 South America Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 105 South America Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 106 South America Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 107 South America Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 108 South America Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 109 South America Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 110 South America Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 111 South America Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 112 South America Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 113 South America Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 114 South America Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 115 South America Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 116 South America Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 117 South America Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 118 South America Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 119 South America Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 120 South America Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
Table 121 Middle East & Africa Biodefense Market Outlook, By Country (2021-2030) ($MN)
Table 122 Middle East & Africa Biodefense Market Outlook, By Product (2021-2030) ($MN)
Table 123 Middle East & Africa Biodefense Market Outlook, By Anthrax (2021-2030) ($MN)
Table 124 Middle East & Africa Biodefense Market Outlook, By Botulism (2021-2030) ($MN)
Table 125 Middle East & Africa Biodefense Market Outlook, By Cholera (2021-2030) ($MN)
Table 126 Middle East & Africa Biodefense Market Outlook, By Influenza (2021-2030) ($MN)
Table 127 Middle East & Africa Biodefense Market Outlook, By Nuclear (2021-2030) ($MN)
Table 128 Middle East & Africa Biodefense Market Outlook, By Smallpox (2021-2030) ($MN)
Table 129 Middle East & Africa Biodefense Market Outlook, By Other Products (2021-2030) ($MN)
Table 130 Middle East & Africa Biodefense Market Outlook, By Detection Device (2021-2030) ($MN)
Table 131 Middle East & Africa Biodefense Market Outlook, By Assays (2021-2030) ($MN)
Table 132 Middle East & Africa Biodefense Market Outlook, By Identifiers (2021-2030) ($MN)
Table 133 Middle East & Africa Biodefense Market Outlook, By Samplers (2021-2030) ($MN)
Table 134 Middle East & Africa Biodefense Market Outlook, By Detectors (2021-2030) ($MN)
Table 135 Middle East & Africa Biodefense Market Outlook, By Triggering Devices (2021-2030) ($MN)
Table 136 Middle East & Africa Biodefense Market Outlook, By Other Detection Devices (2021-2030) ($MN)
Table 137 Middle East & Africa Biodefense Market Outlook, By Application (2021-2030) ($MN)
Table 138 Middle East & Africa Biodefense Market Outlook, By Military (2021-2030) ($MN)
Table 139 Middle East & Africa Biodefense Market Outlook, By Civilian (2021-2030) ($MN)
Table 140 Middle East & Africa Biodefense Market Outlook, By End User (2021-2030) ($MN)
Table 141 Middle East & Africa Biodefense Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 142 Middle East & Africa Biodefense Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
Table 143 Middle East & Africa Biodefense Market Outlook, By Government Institutions (2021-2030) ($MN)
Table 144 Middle East & Africa Biodefense Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 バイオディフェンスとは、生物学的な脅威、特に感染症やバイオテロなどから人々や国家を守るための戦略や技術のことを指します。これには、病原体の監視、予防接種、抗ウイルス治療、迅速な診断技術、感染症に対する医療システムの強化などが含まれます。バイオディフェンスは国防や公衆衛生の一部であり、感染症が流行するリスクを低減し、アウトブレイクが発生した際にはその影響を最小限に抑えることを目的としています。 バイオディフェンスの種類には、いくつかの分野があります。一つは、物理的な防御です。これには、病原体の拡散を防ぐための隔離や、感染者の特定、アクセス制限などが含まれます。次に、化学的防御があり、これは抗生物質やワクチンの開発を通じて行われます。さらに、生物的防御としては、病原体の流行を監視し、早期に警戒を発するための疫学監視が重要です。 バイオディフェンスの用途は多岐にわたります。国家レベルでは、感染症の流行に対処するための政策やプログラムを策定します。また、特定の病気が流行した際に、迅速に対応するための体制を整えることが求められます。公共の健康を保護するためには、ワクチン接種キャンペーンや感染症対策の教育も不可欠です。加えて、病原体の研究を通じて新たな治療法やワクチンの開発に取り組むことも含まれます。このような取り組みは、過去のパンデミックからの教訓を基にしており、より迅速かつ効果的に感染症に対処できる力を蓄えることを目的としています。 関連技術としては、情報通信技術やバイオテクノロジーの進展が挙げられます。情報通信技術は、監視やデータ収集、情報の共有において重要な役割を果たします。疫学データや感染症の進行状況をリアルタイムで追跡することで、迅速な対応が可能になります。バイオテクノロジーは、新しいワクチンや治療法の開発を加速させるために利用され、遺伝子工学や合成生物学などの技術が活用されています。これにより、感染症の原因となる病原体の特性を早期に解明し、効果的な対策を講じることが可能になります。 さらに、国際的な協力もバイオディフェンスにおいて重要です。感染症は国境を超えて広がることが多いため、各国が協力して情報を共有し、共同で研究や対策を行う必要があります。世界保健機関（WHO）などの国際機関は、感染症の監視や対策の指導、国際規模での協力の促進に寄与しています。また、特にバイオテロリズムに対する防御にも国際的な連携が求められます。テロ行為に対する備えは、各国がその経験や知識を共有し合うことで強化されます。 バイオディフェンスの取り組みは、今後も進化し続けることが期待されています。新たな病原体の出現に加え、気候変動や人口増加などが感染症のリスクを高めているため、継続的な研究と対策が求められます。また、一般市民の意識を高めることも重要です。公衆衛生の重要性を理解し、感染予防策を実践することが、社会全体の安全につながるからです。このように、バイオディフェンスは、医療・科学・行政など、多くの分野の協力に依存しており、現代社会において欠かせない課題となっています。 |
